NOVAVAX INC — Director's Dealing 2012

Mar 9, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2012-03-01

Reporting Person: Erck Stanley C (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-03-01	Options-right to buy	$1.28	A	900000	Acquired	2022-03-01	Common Stock (900000)	Direct

Footnotes

F1: Options shall vest in four equal annual installments beginning on the first anniversary of the date of grant.